The Shotlee Journal
Browse Shotlee articles about Ozempic.
Showing 9 / 1086 Ozempic articles
Kylie Jenner promoted pomegranate-flavored Cutting Jelly as a digestion and debloating aid in a January 10 TikTok video. Dubbed 'Korean Ozempic,' the product drew sharp criticism for irresponsible endorsement. Fans question its safety compared to proven GLP-1 medications.
New research challenges fears of quick weight regain after stopping GLP-1 drugs like Ozempic and Wegovy. Real-world data reveals many patients sustain their losses. Experts say durability is possible without lifelong treatment.
Sun Pharmaceutical Industries secures approval to manufacture and sell generic Wegovy in India. The generic semaglutide, branded Noveltreat, launches after March 2026 patent expiry. Indian firms race to tap the booming GLP-1 weight loss market.
Radio host Matt Cooper reveals his journey as an early Ozempic adopter for type 2 diabetes. He defends users struggling with weight, sharing how the GLP-1 drug curbs appetite and led to gallbladder removal. Learn from his candid experiences on semaglutide benefits and challenges.
A scientific review shows certain affordable foods and drinks, including a 4p cup of green tea, could mimic GLP-1 inhibitors used in weight loss drugs. These natural compounds may support appetite regulation and blood sugar control. However, experts caution they are not direct alternatives to medications like Ozempic.
Stars using GLP-1 medications like Ozempic for dramatic weight loss are sparking talk of 'Ozempic face': sunken cheeks, new wrinkles, and sagging skin. Cleveland Clinic endocrinologist Vinni Makin notes this gaunt look stems from rapid fat loss. Public figures face scrutiny as the trend grows.
A new University of Oxford study reveals that GLP-1 users regain weight rapidly after stopping medications like Ozempic, with cardiometabolic benefits reversing within two years. This underscores the need for portion-controlled, nutrient-dense foods to maintain satiety on fewer calories. Food innovation will play a key role in supporting former users.
CDC 2024 data shows US obesity rates dipping for the first time in decades, thanks to Ozempic and GLP-1 drugs. Originally a diabetes treatment, these medications mimic GLP-1 hormones for dramatic weight loss. Learn the serendipitous science behind them and their broader implications.
GLP-1 drugs like Ozempic and Mounjaro have revolutionized weight loss, and the next wave—GLP-3s such as retatrutide—promises even greater results. Eli Lilly's phase 3 trial revealed up to 28.7% body weight loss in 48 weeks. Discover monthly injections, oral pills, and emerging indications for 2026.
